| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 774 | 2016 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 609 | 2018 |
| Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison C La Fougere, A Zwergal, A Rominger, S Förster, G Fesl, M Dieterich, ... Neuroimage 50 (4), 1589-1598, 2010 | 502 | 2010 |
| Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version … I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ... European journal of nuclear medicine and molecular imaging 46, 540-557, 2019 | 499 | 2019 |
| Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment S Dresel, J Krause, KH Krause, C LaFougere, K Brinkbäumer, HF Kung, ... European journal of nuclear medicine 27, 1518-1524, 2000 | 390 | 2000 |
| Molecular imaging of gliomas with PET: opportunities and limitations C la Fougere, B Suchorska, P Bartenstein, FW Kreth, JC Tonn Neuro-oncology 13 (8), 806-819, 2011 | 354 | 2011 |
| PET and SPECT in epilepsy: a critical review C La Fougère, A Rominger, S Förster, J Geisler, P Bartenstein Epilepsy & Behavior 15 (1), 50-55, 2009 | 305 | 2009 |
| Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT J Schwenck, H Rempp, G Reischl, S Kruck, A Stenzl, K Nikolaou, ... European journal of nuclear medicine and molecular imaging 44, 92-101, 2017 | 291 | 2017 |
| Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, ... Neuro-oncology 13 (3), 307-316, 2011 | 270 | 2011 |
| The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder KH Krause, SH Dresel, J Krause, C la Fougere, M Ackenheil Neuroscience & Biobehavioral Reviews 27 (7), 605-613, 2003 | 254 | 2003 |
| [18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma M Hutterer, M Nowosielski, D Putzer, NL Jansen, M Seiz, M Schocke, ... Neuro-oncology 15 (3), 341-351, 2013 | 251 | 2013 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 237 | 2019 |
| A whole-body FDG-PET/CT dataset with manually annotated tumor lesions S Gatidis, T Hepp, M Früh, C La Fougère, K Nikolaou, C Pfannenberg, ... Scientific Data 9 (1), 601, 2022 | 226 | 2022 |
| Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases LA Hoffmann, S Jarius, HL Pellkofer, M Schueller, M Krumbholz, F Koenig, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (7), 767-773, 2008 | 217 | 2008 |
| Two decades of SPECT/CT–the coming of age of a technology: an updated review of literature evidence O Israel, O Pellet, L Biassoni, D De Palma, E Estrada-Lobato, ... European journal of nuclear medicine and molecular imaging 46, 1990-2012, 2019 | 215 | 2019 |
| MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? NL Jansen, V Graute, L Armbruster, B Suchorska, J Lutz, S Eigenbrod, ... European journal of nuclear medicine and molecular imaging 39, 1021-1029, 2012 | 205 | 2012 |
| In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors A Rominger, T Saam, E Vogl, C Übleis, C la Fougère, S Förster, A Haug, ... Journal of nuclear medicine 51 (2), 193-197, 2010 | 195 | 2010 |
| Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ... Neurology 84 (7), 710-719, 2015 | 191 | 2015 |
| Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ... The Lancet Oncology 21 (4), 581-592, 2020 | 186 | 2020 |
| Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases TF Jakobs, RT Hoffmann, K Dehm, C Trumm, HJ Stemmler, K Tatsch, ... Journal of Vascular and Interventional Radiology 19 (8), 1187-1195, 2008 | 178 | 2008 |
Konstantin NikolaouUniversity of Tuebingen, Department of RadiologyVerified email at med.uni-tuebingen.de
